Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.
about
Vaccines against human diarrheal pathogens: current status and perspectivesElimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity.Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.Intracellular delivery of messenger RNA by recombinant PP7 virus-like particles carrying low molecular weight protamine.Antigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureusArmored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma.Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma.The alien replicon: Artificial genetic constructs to direct the synthesis of transmissible self-replicating RNAs: In vivo synthesised heterologous (alien) RNA constructs are capable of initiating self-replication following transmission to the host oMethods for Preparation of MS2 Phage-Like Particles and Their Utilization as Process Control Viruses in RT-PCR and qRT-PCR Detection of RNA Viruses From Food Matrices and Clinical Specimens.Nucleic acid vaccination strategies against infectious diseases.The application of virus-like particles as vaccines and biological vehicles.Nanomedicine approaches to improve cancer immunotherapy.Rewriting nature's assembly manual for a ssRNA virus.RETRACTED ARTICLE: Cell-specific delivery of messenger RNA and microRNA by recombinant MS2 virus-like particles carrying cell-penetrating peptide.One-plasmid double-expression His-tag system for rapid production and easy purification of MS2 phage-like particles.
P2860
Q33578045-96F8A803-CD68-4B43-93B4-B17030341944Q33679779-12CC0CA1-9A80-4677-AC23-61BC3178D0CAQ35963673-7484D8F9-2367-42BF-9E67-E8A1D0690F23Q36032757-0A184127-3DD1-4E79-B9D4-4B0276B0A844Q36380959-6CA7077F-F16C-4878-8B4C-DA4A686684E4Q37269190-2CDC3833-8DF3-4B91-8E5F-CFA1464CB02BQ37644875-14C9DFE3-1FB2-4C96-8274-E3E672493AEAQ38266429-FBBD9560-8605-470F-BCEB-35F67946D810Q38364815-010D1D73-8EA7-4A37-B45A-3FED910C9317Q38586079-5E7BF9BA-41FD-4B2B-A3AE-F432EDD3C911Q38603912-9F08D4F1-3B0C-45BE-802C-96F6E5BB4CDAQ39179977-24FFF70A-7618-429E-A5CC-A4036615065FQ45325473-1F839471-2629-42FF-B6F0-5F9FE9BE32DDQ45343688-7F441830-AFC6-40FF-B8EF-7288A561351EQ47566359-BF0BBCB1-0E71-48AE-86EF-059D8C2FE411
P2860
Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Messenger RNA vaccine based on ...... icles against prostate cancer.
@en
Messenger RNA vaccine based on ...... icles against prostate cancer.
@nl
type
label
Messenger RNA vaccine based on ...... icles against prostate cancer.
@en
Messenger RNA vaccine based on ...... icles against prostate cancer.
@nl
prefLabel
Messenger RNA vaccine based on ...... icles against prostate cancer.
@en
Messenger RNA vaccine based on ...... icles against prostate cancer.
@nl
P2093
P2860
P356
P1476
Messenger RNA vaccine based on ...... icles against prostate cancer.
@en
P2093
Jinming Li
Lunan Wang
Tingting Jia
P2860
P304
P356
10.1002/IJC.28482
P577
2013-10-08T00:00:00Z